Covid-19

Antibodies attack Covid-19
#Covid-19 #Dendritic cells #Immunity #Oncology

Scientists redirect Covid-19 immune memory to fight cancer

Scientists have developed a novel cancer vaccine platform that transforms the synchronised mass immune memory generated through SARS-CoV-2 infection and vaccination into a powerful ally against cancer.  The study by scientists from Celloram, University Hospitals, and Case Western Reserve University was published in Nature Communications. Read More

#Cancer Research #Editor's Choice #News

Influenza
#Covid-19 #Flu #Immunology / Virology & Vaccines #Respiratory #University of Buffalo

Nanoparticle vaccine shows potential against ‘tripledemic’

A single-shot vaccine under development at the University at Buffalo in the US could protect against flu, Covid-19 and respiratory syncytial virus (RSV) simultaneously.   In a study published in Science Advances, the researchers found that their three-in-one vaccine triggered protective immunity against all three respiratory… Read More

#Editor's Choice #News

#Bladder cancer #Covid-19 #Drug discovery #Heart disease #Lung disease #Oncology

This week in Drug Discovery (22-26 June) 

News round-up for 22–26 June by Bruno Quinney, Content Team at DDW.  This week, the Summer issue of DDW is now available to read. Elsewhere, researchers have uncovered clues explaining risks of heart disease, lung disease, Covid-19 and cancer.    The top stories: … Read More

#News

#Covid-19 #Genetic profiling #Lung disease #University of Edinburgh

Genetic variation increases Covid-19 and lung disease risk 

A genetic difference carried by nearly one in three could increase the risk of Covid-19 and lung disease, a new study shows.  Researchers at the University of Edinburgh found the genetic variant alters a newly discovered enzyme found in lung tissue, disrupting the function of a previously unknown protein. This… Read More

#News

Vaccine
#Covid-19 #Immunology / Virology & Vaccines #University of Cambridge

‘Universal’ vaccine could protect from several viruses at once 

A novel ‘universal’ vaccine has been engineered to provide protection from thousands of variants in one single dose.  Results from a first-in-human clinical trial, published in the Journal of Infection, show the vaccine protected participants from multiple Sarbeco coronaviruses, a large group of viruses including SARS-CoV-2, as… Read More

#News

Bacteria in Petri dishes
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Covid-19 #mRNA #mRNA-based vaccines #Oncology #RNA

How drug discovery is tackling global health challenges

This is the latest episode of the free DDW Narrated Podcast. The episode covers two articles written for DDW Volume 25, Issue 2, Spring 2024. The first article is called ‘Why more work is needed to fight antimicrobial resistance’. In the article, DDW Editor Reece Armstrong speaks to Professor… Read More

#Featured Podcasts

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

DDW Highlights: 18 November 2025

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, groundbreaking research showed the Covid-19 mRNA vaccine could boost cancer response. Elsewhere,… Read More

#Podcasts

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

This week in Drug Discovery (10 – 14 November) 

News round-up for 10 – 14 November by Bruno Quinney, Content Team at DDW.  This week’s top story comes from groundbreaking research showing the Covid-19 mRNA vaccine boosts the immune system’s cancer response. The theme of UK investment dominates other headlines, while a report shows an effective… Read More

#News

Covid-19 vaccine
#Covid-19 #DNA technology #Drug discovery #Immunology / Virology & Vaccines #Infectious diseases

The potential of DNA platforms for infectious disease vaccines 

Stacy R. Lindborg, President and Chief Executive Officer of IMUNON, discusses why research is needed to inform better strategies for infectious diseases such as Covid-19 and a new, multivalent non-viral DNA approach to vaccine development that has the potential to address continued unmet needs in the field. … Read More

#Exclusive Content

Long Covid
#Covid-19 #Japan #Therapeutic targets

Long Covid breakthrough offers hope of new therapeutic target

Researchers from Yokohama City University in Japan have made a breakthrough in understanding Covid ‘brain fog’, providing clues for a new therapeutic target.  Researchers used a novel imaging technique to visualise AMPA receptors (AMPARs), key molecules for memory and learning, in the living brain. They… Read More

#News

Long Covid concept
#Covid-19 #Genetics / genomics #Long Covid #Oncology #Spatial biology

Enhancing cancer and long Covid research

Genomic and spatial technologies are helping to bring greater insights into cancer and diseases such as long Covid, writes Jack DiGiovanna, Chief Science Officer at Velsera. Emerging genomic and spatial technologies are transforming research on complex diseases like cancer and long Covid. These advancements offer unprecedented precision in diagnostics and… Read More

#Cancer Research #Exclusive Content

#Covid-19 #Covid-19 vaccine #Immunology / Virology & Vaccines #United States

Medical societies sue RF Kennedy Jr for “unlawful” vaccine changes

A group of medical professional societies have filed a lawsuit against Robert F Kennedy Jr in the US District Court for the District of Massachusetts to defend vaccine policy, and to put an end to what they call the Secretary’s “assault on science, public health and evidence-based medicine”. … Read More

#News #Trending News

Covid-19
#Covid-19 #Immunology / Virology & Vaccines #Preclinical development #Rocketvax #SARS-CoV-2

Robust preclinical results for live-attenuated SARS-CoV-2 vaccine

Live-attenuated SARS-CoV-2 vaccine candidate, OTS-228, has demonstrated exceptional safety, efficacy, and genomic stability in preclinical animal models.  The vaccine was developed under the scientific leadership of Professor Dr Volker Thiel, Chief Scientist of Rocketvax and Professor of Virology at the University of Bern.  The latest… Read More

#News #Trending News

Therapeutic antibodies
#Alzheimer's #Antibodies #Cancer #Covid-19 #Engineered antibodies #Immunology #Janssen #Monoclonal antibodies #Rare disease #Therapeutic Antibodies

Podcast: Where is the innovation in the therapeutic antibody market?

This is the latest episode of the free DDW narrated podcast, titled “Where is the innovation in the therapeutic antibody market?”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Finding the North Star of therapeutic antibodies” and “Which diseases… Read More

#News

HIV cell
#Antivirals #Covid-19 #Events #HIV #Immunology / Virology & Vaccines

Breaking virology news from CROI 2025

Several companies shared new trial data at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco, US.  Once-yearly lenacapavir for HIV prevention Gilead Sciences presented the first data from its ongoing Phase I study investigating two once-yearly formulations of lenacapavir, an injectable HIV-1 capsid… Read More

#News #Trending News